Literature DB >> 18350352

Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population.

Jun-Dong Chang1, Mina Hur, Sang-Soo Lee, Je-Hyun Yoo, Kyu Man Lee.   

Abstract

Major thrombophilic mutations have been identified as risk factors for nontraumatic osteonecrosis of the femoral head (ONFH) in Caucasians. We asked whether the genetic background of patients with ONFH in the Korean population was similar. We analyzed factor V G1691A mutation (factor V Leiden), prothrombin G20210A mutation, and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in 71 patients (53 men, 18 women) with ONFH. We classified these patients as 51 alcohol-induced, 18 idiopathic, one steroid-induced, and one dysbaric. We recruited 200 normal control subjects (128 men, 72 women). We used multiplex PCR/restriction fragment length polymorphism for each genotyping. We observed neither factor V Leiden nor prothrombin G20210A mutation. Although methylenetetrahydrofolate reductase A1298C genotypes were not associated with osteonecrosis, methylenetetrahydrofolate reductase C677T variant genotypes increased the risk of ONFH compared with 677CC. Odds ratios of 677CT and 677CT+TT were 2.00 (95% confidence interval, 1.05-3.81) and 1.96 (95% confidence interval, 1.07-3.59), respectively, compared with 677CC. Our data suggest methylenetetrahydrofolate reductase C677T polymorphism plays a role in the pathogenesis of osteonecrosis in the Korean population. It also implies the genetic risk profile of ONFH may differ among ethnic populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350352      PMCID: PMC2311470          DOI: 10.1007/s11999-008-0147-1

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  25 in total

1.  The 677C-->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head.

Authors:  Charalampos G Zalavras; Konstantinos N Malizos; Eleni Dokou; George Vartholomatos
Journal:  Haematologica       Date:  2002-01       Impact factor: 9.941

2.  The C677T mutation of the methylenetetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan.

Authors:  L A Hsu; Y L Ko; S M Wang; C J Chang; T S Hsu; C W Chiang; Y S Lee
Journal:  Hum Hered       Date:  2001       Impact factor: 0.444

3.  Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.

Authors:  Z J Jun; T Ping; Y Lei; L Li; S Y Ming; W Jing
Journal:  Clin Lab Haematol       Date:  2006-04

4.  Factor V Leiden and prothrombin gene mutations in femoral head osteonecrosis.

Authors:  Charalampos G Zalavras; George Vartholomatos; Eleni Dokou; Konstantinos N Malizos
Journal:  Thromb Haemost       Date:  2002-06       Impact factor: 5.249

5.  Procoagulants and osteonecrosis.

Authors:  Lynne C Jones; Michael A Mont; Tung B Le; Michelle Petri; David S Hungerford; Ping Wang; Charles J Glueck
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

6.  Genetic variation of the methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and a new polymorphism in intron 7.

Authors:  S H Hong; J Song; J Q Kim
Journal:  Mol Cell Probes       Date:  2001-04       Impact factor: 2.365

7.  Potential aetiological factors concerning the development of osteonecrosis of the femoral head.

Authors:  C Zalavras; Z Dailiana; M Elisaf; E Bairaktari; P Vlachogiannopoulos; A Katsaraki; K N Malizos
Journal:  Eur J Clin Invest       Date:  2000-03       Impact factor: 4.686

8.  Hypofibrinolysis, thrombophilia, osteonecrosis.

Authors:  C J Glueck; R A Freiberg; R N Fontaine; T Tracy; P Wang
Journal:  Clin Orthop Relat Res       Date:  2001-05       Impact factor: 4.176

9.  Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.

Authors:  Yanhui Lu; Yanfen Zhao; Guozhang Liu; Xiaoling Wang; Zhihong Liu; Baiping Chen; Rutai Hui
Journal:  Thromb Res       Date:  2002-04-01       Impact factor: 3.944

10.  Multiplex PCR for simultaneous detection of 677 C-->T and 1298 A-->C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk.

Authors:  Ping Yi; Igor Pogribny; S Jill James
Journal:  Cancer Lett       Date:  2002-07-26       Impact factor: 8.679

View more
  28 in total

1.  Association between MTHFR C677T polymorphism and osteonecrosis of the femoral head: a meta-analysis.

Authors:  Xi-fu Shang; Hong Su; Wei-wei Chang; Chen-cheng Wang; Qin Han; Zhi-wei Xu
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

2.  Osteonecrosis of the femoral head: genetic basis.

Authors:  Tracy Wang; Bouziane Azeddine; Wayne Mah; Edward J Harvey; David Rosenblatt; Chantal Séguin
Journal:  Int Orthop       Date:  2018-10-17       Impact factor: 3.075

3.  The Prevalence of the Prothrombin (F2) 20210G>A Mutation in a Cohort of Sri Lankan Patients with Thromboembolic Disorders.

Authors:  K M D Gunathilake; U N D Sirisena; P K D Nisansala; H W W Goonasekera; R W Jayasekara; V H W Dissanayake
Journal:  Indian J Hematol Blood Transfus       Date:  2014-09-02       Impact factor: 0.900

4.  Bilateral Legg-Calve-Perthes Disease and Kienbock's Disease in a Child With Factor V Leiden Thrombophilia: A Case Report.

Authors:  Heather L Baltzer; Scott Riester; Steven L Moran
Journal:  Hand (N Y)       Date:  2016-02-26

5.  Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population.

Authors:  Yanqiong Zhang; Xiangying Kong; Rongtian Wang; Shangzhu Li; Yanfang Niu; Liuluan Zhu; Weiheng Chen; Na Lin
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

6.  Endothelial nitric oxide synthase gene polymorphisms and the risk of osteonecrosis of the femoral head in systemic lupus erythematosus.

Authors:  Hak Soo Kim; Sang-Cheol Bae; Tae-Ho Kim; Shin-Yoon Kim
Journal:  Int Orthop       Date:  2013-06-18       Impact factor: 3.075

7.  Meta-analysis of Factor V Leiden G1691A polymorphism and osteonecrosis of femoral head susceptibility.

Authors:  Xifu Shang; Zhengliang Luo; Xu Li; Fei Hu; Qichun Zhao; Wenzhi Zhang
Journal:  Biomed Rep       Date:  2013-04-09

Review 8.  Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Contributes to Osteonecrosis of the Femoral Head Susceptibility: Evidence from a Systematic Review and Meta-analysis.

Authors:  Mohammad R Sobhan; Masoud Mahdinezhad-Yazdi; Mansour Moghimi; Kazem Aghili; Mohammadali Jafari; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  Arch Bone Jt Surg       Date:  2018-11

9.  Association of Thrombophilic Factors in Pathogenesis of Osteonecrosis of Femoral Head in Indian Population.

Authors:  Tushar N Rathod; M B Tayade; Shrimati D Shetty; Pratap Jadhav; Ashwin Hemant Sathe; Shubhranshu S Mohanty
Journal:  Indian J Orthop       Date:  2020-07-02       Impact factor: 1.251

Review 10.  Osteonecrosis of the Femoral Head in Patients with Hypercoagulability-From Pathophysiology to Therapeutic Implications.

Authors:  Elena Rezus; Bogdan Ionel Tamba; Minerva Codruta Badescu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.